(Q44504891)

3 December 2017

Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma (English)

1 reference

3 December 2017

3

Luis E Fayad

0 references

author name string

Yasuhiro Oki

1

1 reference

3 December 2017

Peter McLaughlin

2

1 reference

3 December 2017

Barbara Pro

4

1 reference

3 December 2017

Paul F Mansfield

5

1 reference

3 December 2017

Gary L Clayman

6

1 reference

3 December 2017

L Jeffrey Medeiros

7

1 reference

3 December 2017

Larry W Kwak

8

1 reference

3 December 2017

Pramod K Srivastava

9

1 reference

3 December 2017

Anas Younes

10

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

3 December 2017

1 reference

3 December 2017

109

1 reference

3 December 2017

77-83

1 reference

3 December 2017

1

1 reference

Cutting edge: CD91-independent cross-presentation of GRP94(gp96)-associated peptides.

3 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22389

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22389

7 January 2021

Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22389

7 January 2021

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22389

7 January 2021

Heat shock protein-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22389

7 January 2021

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22389

7 January 2021

Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22389

7 January 2021

CD91: a receptor for heat shock protein gp96

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22389

7 January 2021

Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22389

7 January 2021

The challenges of bringing autologous HSP-based vaccines to commercial reality

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22389

7 January 2021

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22389

7 January 2021

Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22389

7 January 2021

Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22389

7 January 2021

Identifiers

DOI

10.1002/CNCR.22389

1 reference

3 December 2017

1 reference